Researchers from The Florey and Austin Health have unveiled groundbreaking findings that pave the way for early detection and potentially preventive treatments for Parkinson’s disease – up to two to three decades prior to the manifestation of its classical symptoms.
Parkinson’s disease, a profound neurodegenerative disorder, is often associated with older age, but its onset begins stealthily in midlife, silently evolving for decades before becoming clinically apparent.
According to Professor Kevin Barnham, by the time Parkinson’s disease becomes diagnosable through overt symptoms, approximately 85% of the critical neurons associated with motor coordination may already be irreparably damaged.
In this light, the recent findings from the study, published in Neurology, illuminate a hopeful path towards potentially detecting and managing the disease much earlier than previously thought possible.
The Revealing Biomarker and PET Scans
The research team, led by Professor Barnham, discerned that a known biomarker, F-AV-133, when used in conjunction with positron emission tomography (PET) scans, not only enabled the diagnosis of Parkinson’s disease but also accurately tracked the progression of neurodegeneration.
Their investigation involved scanning individuals with Parkinson’s disease, a control group, and individuals with Rapid Eye Movement Sleep Behavior Disorder (RBD), which is a strong precursor to Parkinson’s.
Even though clinical symptoms did not demonstrate significant alterations over two years, PET scans strikingly unveiled “significant neuronal loss” in three vital brain regions in those with Parkinson’s disease.
This highlights the remarkable sensitivity of F-AV-133 in monitoring neurodegeneration compared to current diagnostic modalities.
A Protracted Timeline of Neuronal Loss
Intriguingly, mathematical modelling suggested that neuronal loss in Parkinson’s disease spans approximately 33 years – with about 10.5 years passing before detectability via PET scan, another 6.5 years before motor symptoms arise, and an additional 3 years before clinical diagnosis is confirmed.
This equates to a staggering 22.5 years of neuronal loss before the disease can be clinically diagnosed.
Unlocking New Avenues for Screening and Treatment Protocols
These findings inaugurate new avenues for developing screening procedures that could potentially diagnose and facilitate the treatment of Parkinson’s disease up to a decade earlier than currently feasible.
Furthermore, this could offer a robust tool for identifying suitable candidates for clinical trials, potentially steering the direction of future Parkinson’s research and treatment strategies.
The Link between RBD and Parkinson’s Disease
RBD, characterized by violent and active behavior during vivid, often unpleasant dreams due to a lack of muscle atonia (sleep paralysis), holds a crucial relationship with Parkinson’s disease.
With approximately 90% of individuals with RBD eventually developing a Parkinsonian condition and about half of Parkinson’s patients exhibiting RBD, it is a pivotal warning sign of early Parkinson’s disease and warrants attentive neurological evaluation.
Key Takeaways
This revolutionary research blossoms as a beacon of hope, unveiling a path toward early detection, proactive management, and potentially preventive treatments for Parkinson’s disease, thereby potentially altering the course and improving the quality of life for individuals who may be affected in the future.
The intersection of RBD, PET scans, and biomarker utility presents a promising future in our understanding and approach to neurodegenerative diseases and warrants further exploration and application in larger, diverse populations.
If you care about Parkinson’s disease, please read studies about Vitamin E that may help prevent Parkinson’s disease, and Vitamin D could benefit people with Parkinson’s disease.
For more information about brain health, please see recent studies about new way to treat Parkinson’s disease, and results showing COVID-19 may be linked to Parkinson’s disease.
The research findings can be found in Neurology.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
